Table 1. Overview of the study approach.

GSE ID	GPL ID	The number of resistant patients	The number of sensitive patients	ER-STATE
GSE1378	GPL1223	28	32	Positive
GSE1379	GPL1223	28	32	Positive
GSE6532A	GPL96	12	54	Positive
GSE6532B	GPL97	19	80	Positive
GSE6532C	GPL570	28	59	Positive
GSE6532D	GPL96	16	32	Positive
GSE6532E	GPL97	21	48	Positive
GSE12093	GPL96	20	116	Positive
GSE16446	GPL570	19	19	Negative